Facebook
Twitter
LinkedIn
ForwardAnticoagulation for Superficial Vein Thrombosis/Thrombosis Debates: Aggressive vs. Conservative- Management of Superficial Thrombophlebitis
This activity will provide an overview of superficial vein thrombosis. The intent of this activity is to improve the learners' competency through this introduction to management of superficial thrombophlebitis.
Steps to Successfully Complete This Activity
To participate in this educational activity please follow the steps listed below.
If you are new to the ACP Online Education Center we require that you register prior to viewing any activity. Click the Register link located in the top right corner of this screen to do so. If you are already a registered user log in and click the TAKE COURSE button that will appear in the Course Summary box.
- To begin the activity click the START COURSE button.
- Progress through course content by using the NEXT button.
- Complete all required items in the course.
- Participants must score 80% or greater on the Post-Test to advance and receive credit. They are given three attempts to meet this threshold.
- Track your progress using the Course Progress menu.
- On the final page of the activity a link will be provided to download your certificate.
Target Audience
The content of this activity is designed to meet the needs of the following target audience: phlebologists, general surgeons, vascular surgeons, interventional radiologists, interventional cardiologists, vascular medicine practitioners, dermatologists, dermatologic surgeons, family practice and internal medicine practitioners, plastic surgeons, obstetricians and gynecologists, cardiologists, and any other healthcare professional currently or planning on treating patients with venous disease.
Learning Objectives
As a result of this activity, the participant should be able to:
- Identify the current aCCP guidelines for treatment of Superficial Thrombophlebitis.
- Recognize the risk of serious complications in patients with Superficial Thrombophlebitis.
- Summarize recent medical literature regarding the treatment of Superficial Thrombophlebitis.
- Formulate a plan of action for patients with various Superficial Thrombophlebitis presentations.
| NAME | ROLE | COMMERCIAL INTEREST | TYPE OF RELATIONSHIP |
|---|---|---|---|
| Stephen R. Bunker, MD | Content Reviewer | None | n/a |
| Heather Durband, BS | Staff | None | n/a |
| Paula Heggerick, BS, RVT, RDMS, RPhS, FSVU | Content Reviewer | None | n/a |
| Philip Hertzman, MD, FACP, FAAFP, FACPh | Content Reviewer | None | n/a |
| Nick Morrison, MD, FACS, FACPh, RPhS | Content Reviewer | Medi; Sapheon | Speaker; Principal Investigator |
| Eric Mowatt-Larssen MD, FACPh, RPhS | Speaker | BTG International, Inc. | Consultant |
| Diana Neuhardt, RVT, RPhS | Scientific Committee/Planner | None | n/a |
| Marlin Schul MD, MBA, RVT, FACPh | Speaker | Vein Directory; BTG International, Inc. | Consultant; Principal Investigator |
| Julianne Stoughton, MD, FACS | Scientific Committee/Planner | None | n/a |
Disclaimer
The views and opinions expressed in this activity are those of the faculty and do not necessarily represent the views of the ACP. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting professional use of any of the information provided herein. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of ACP Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Discussion of Off-Label Use
Although no longer required by the Accreditation Council for Continuing Medical Education (ACCME), ACP CME requests all faculty to inform learners of any products they will discuss that are off-label or investigational.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
Review & Recertification
This course was reviewed and recertified for AMA PRA Category 1 CreditTM in March 2015 and February 2017.
Available Credit
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Attendance